Vishen LakhianiFounder of Mindvalley | NYT Bestselling Author | Transforming Lives Globally

How Gene Therapy is Slowing Down Aging

19 Apr 2025 · 0 min

Watch on YouTube

0:08

Vishen Lakhiani explains how peptide-based gene therapies might slow aging. Follistatin gene therapy blocks myostatin, which limits muscle growth. A single injection raises follistatin to youthful levels and lasts about a year, potentially reversing muscle loss that begins after age 30.

Questions this video answers

Ozempic and insulin.

Myostatin.

After 30.

About a year.

Ozempic, which is a very popular peptide for fat loss. Insulin is a peptide. Peptides are amino acids in your body. Your body naturally makes them right.
How does gene therapy work for anti aging?
This is a peptide gene therapy. As you get older, your peptides decrease. Follistatin is a peptide that helps with strength and it inhibits an enzyme called myostatin. And myostatin sets a limit on how much muscle you can put on. So basically it's like, okay, I have more follow statin, I can put on muscle easier, which is a big problem. As you age, you lose muscle. After 30, you just. It's a natural process. So follow statin gene therapy, it increases your follow statin levels back to a youthful level with one injection. It lasts for about a year and it tells your own body to make more follistatin. So that's why it's a gene therapy, because we're using what's called a vector to introduce a follow statin gene into your cell.
So a new signal is being communicated to our cells.